Medical Device FSH Test Substrate Error Causes Failed Tests and Delayed Results
bioMerieux is recalling VIDAS FSH test kits due to substrate errors that prevent the test from running, requiring repeated testing and delaying results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II device recall with a functional defect (substrate error). No illnesses or injuries reported. The hazard is operational—delayed test results—rather than direct patient safety harm.
Plain-English summary
bioMerieux, Inc. is recalling one lot (No. 1008781470) of VIDAS FSH, REF 30407-01, a follicle-stimulating hormone immunoassay test, due to a substrate error. The error prevents the test from being run as intended.
When the substrate error occurs, users cannot complete the test and must run another test to obtain results. This leads to delayed test results. bioMerieux has received an increasing number of complaints related to this substrate error.
The affected product (UDI 03573026156947) was distributed nationwide throughout the United States.
The recalled product
- Product
- VIDAS FSH, REF 30407-01
- Manufacturer
- bioMerieux, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI 03573026156947
- Lot #: 1008781470
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by bioMerieux, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · bioMerieux, Inc.
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · substrate defect
See all →- HighCochlear implant devices recalled for potential internal electronics substrate defect
FDA (Devices) · 2024-07-24
- HighVIDAS Measles IgG Test Kit Recalled Due to Substrate Error
FDA (Devices) · 2022-01-05
- HighVIDAS Clostridium Difficile GDH test substrate error causes test failure
FDA (Devices) · 2022-01-05
- HighVIDAS Estradiol II Test Device Recalled Due to Substrate Error
FDA (Devices) · 2022-01-05
- ModerateVIDAS RUB IgG Diagnostic Test Kit Recalled for Substrate Defect
FDA (Devices) · 2022-01-05